Title: Newer antipsychotics and upcoming molecules for schizophrenia.
Journal: European journal of clinical pharmacology 20130801
Title: Evaluation of dopamine D₂/D₃ and serotonin 5-HT₂A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography.
Journal: Psychopharmacology 20130101
Title: Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults.
Journal: Expert review of clinical pharmacology 20130101
Title: Lurasidone in schizophrenia: new information about dosage and place in therapy.
Journal: Advances in therapy 20121001
Title: Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120901
Title: Iloperidone, asenapine and lurasidone: a primer on their current status.
Journal: Expert opinion on pharmacotherapy 20120901
Title: Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
Journal: CNS drugs 20120901
Title: A review of published evidence reporting on the efficacy and pharmacology of lurasidone.
Journal: Expert opinion on pharmacotherapy 20120801
Title: Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Journal: Clinical schizophrenia & related psychoses 20120701
Title: 5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux.
Journal: Neuroreport 20120509
Title: The role of 5-HT1A receptors in phencyclidine (PCP)-induced novel object recognition (NOR) deficit in rats.
Journal: Psychopharmacology 20120501
Title: Long-term safety and tolerability of lurasidone in schizophrenia: a 12-month, double-blind, active-controlled study.
Journal: International clinical psychopharmacology 20120501
Title: Lurasidone (latuda®): an atypical antipsychotic.
Journal: Issues in mental health nursing 20120501
Title: Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress.
Journal: The international journal of neuropsychopharmacology 20120301
Title: New drugs 2012 part I.
Journal: Nursing 20120301
Title: Lurasidone for schizophrenia: what's different?
Journal: Expert review of neurotherapeutics 20120301
Title: The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses.
Journal: Molecular pharmacology 20120201
Title: Update on the development of lurasidone as a treatment for patients with acute schizophrenia.
Journal: Drug design, development and therapy 20120101
Title: Lurasidone: an atypical antipsychotic for schizophrenia.
Journal: The Annals of pharmacotherapy 20120101
Title: Quantification of lurasidone, an atypical antipsychotic drug, in rat plasma with high-performance liquid chromatography with tandem mass spectrometry.
Journal: Biomedical chromatography : BMC 20111201
Title: Pharmacokinetics of lurasidone, a novel atypical anti-psychotic drug, in rats.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20111201
Title: Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder.
Journal: Schizophrenia research 20111101
Title: Lurasidone: a new treatment option for schizophrenia.
Journal: Drugs of today (Barcelona, Spain : 1998) 20111101
Title: Biological perspectives: update on newer antipsychotic drugs: are they evidence based?
Journal: Perspectives in psychiatric care 20111001
Title: Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats.
Journal: Psychopharmacology 20110901
Title: Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo- and olanzapine-controlled study.
Journal: The American journal of psychiatry 20110901
Title: Comment on the potential utility of the new atypical antipsychotic lurasidone in the geriatric population.
Journal: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20110801
Title: Pharmacokinetics and metabolism update for some recent antipsychotics.
Journal: Expert opinion on drug metabolism & toxicology 20110701
Title: The effects of selective antagonists of serotonin 5-HT7 and 5-HT1A receptors on MK-801-induced impairment of learning and memory in the passive avoidance and Morris water maze tests in rats: mechanistic implications for the beneficial effects of the novel atypical antipsychotic lurasidone.
Journal: Behavioural brain research 20110620
Title: Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.
Journal: Schizophrenia research 20110401
Title: Update on newer antipsychotic drugs.
Journal: Journal of psychosocial nursing and mental health services 20110401
Title: Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.
Journal: Postgraduate medicine 20110301
Title: Lurasidone (Latuda) for schizophrenia.
Journal: The Medical letter on drugs and therapeutics 20110221
Title: Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
Journal: Schizophrenia research 20110201
Title: Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.
Journal: International journal of clinical practice 20110201
Title: Lurasidone for schizophrenia: a brief review of a new second-generation antipsychotic.
Journal: Clinical schizophrenia & related psychoses 20110101
Title: New drugs. Azilsartan medoxomil, belimumab, and lurasidone hydrochloride.
Journal: Journal of the American Pharmacists Association : JAPhA 20110101
Title: Lurasidone: a clinical overview.
Journal: The Journal of clinical psychiatry 20110101
Title: Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity.
Journal: The Journal of pharmacology and experimental therapeutics 20100701
Title: Lurasidone: a new drug in development for schizophrenia.
Journal: Expert opinion on investigational drugs 20091101
Title: Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
Journal: The Journal of clinical psychiatry 20090601
Title: Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
Journal: Behavioural brain research 20080125
Title: Lurasidone (SM-13496), a novel atypical antipsychotic drug, reverses MK-801-induced impairment of learning and memory in the rat passive-avoidance test.
Journal: European journal of pharmacology 20071031
Title: Ishibashi T, et al. Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity. J Pharmacol Exp Ther. 2010 Jul;334(1):171-81.
Title: Sakine Atila Karaca, et al. Development of a validated high-performance liquid chromatographic method for the determination of Lurasidone in pharmaceuticals. Marmara Pharm J. 2017;21 (4): 931-937.
